Subscribe to RSS
DOI: 10.1055/a-2616-4775
Effects of the Medicaid Continuous Enrollment Requirement on Access to Reconstructive Breast Surgery

Introduction. The “continuous enrollment provision” of the Families First Coronavirus Response Act of 2020 (FFCRA) maintained states’ Medicaid enrollments throughout the COVID-19 public health emergency. This study evaluated the impact of the continuous enrollment requirement on Medicaid patients’ access to reconstructive breast surgery. Methods. A retrospective cohort study was conducted on all patients who received reconstructive breast surgery procedures at a large academic institution between July 1st, 2013 and July 1st, 2023. The Medicaid continuous enrollment period was defined as March 18th, 2020 to July 1st, 2023. Univariate analysis, multivariable logistic regression, and difference-in-difference analysis were performed. Results. 3,564 patients were included, of whom 252 patients were insured by Medicaid. Patients’ odds of Medicaid insurance before and during the continuous enrollment period did not differ (p = 0.096). The distribution of Medicaid and non-Medicaid insurance among autologous breast reconstruction patients similarly did not differ during the continuous enrollment period (p = 0.86). Difference-in-difference analysis confirmed that Medicaid prevalence among autologous breast reconstruction patients did not change with the continuous enrollment requirement (p = 0.07). Increased age was predictive of Medicaid insurance (OR 1.043, p < 0.001); however, age-dependent differences decreased during the continuous enrollment period. Patients with non-English language preferences had lower odds of Medicaid insurance (OR 0.38, p = 0.035); this difference remained unchanged with the continuous enrollment requirement (p = 0.59). Conclusions. The continuous enrollment requirement alleviated certain age-dependent barriers for Medicaid patients but may not have addressed other patient-level, system-level, and procedure-specific barriers to reconstructive breast surgery.
Publication History
Received: 31 December 2024
Accepted after revision: 12 May 2025
Accepted Manuscript online:
20 May 2025
© . Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor , NY 10001 New York, USA